Helen McLean

429 total citations
9 papers, 364 citations indexed

About

Helen McLean is a scholar working on Endocrinology, Diabetes and Metabolism, Immunology and Reproductive Medicine. According to data from OpenAlex, Helen McLean has authored 9 papers receiving a total of 364 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Endocrinology, Diabetes and Metabolism, 3 papers in Immunology and 3 papers in Reproductive Medicine. Recurrent topics in Helen McLean's work include Hormonal and reproductive studies (3 papers), Ovarian function and disorders (2 papers) and Complement system in diseases (2 papers). Helen McLean is often cited by papers focused on Hormonal and reproductive studies (3 papers), Ovarian function and disorders (2 papers) and Complement system in diseases (2 papers). Helen McLean collaborates with scholars based in United Kingdom, United States and Denmark. Helen McLean's co-authors include C. S. CORKER, D. T. Baird, K. P. McNatty, A.E. Bolton, William Hunter, Geert Schou, John Philip, Charles S. Corker, Arlette De Coninck and Sue Ellen Cox and has published in prestigious journals such as Blood, The Journal of Clinical Endocrinology & Metabolism and Journal of Endocrinology.

In The Last Decade

Helen McLean

9 papers receiving 340 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Helen McLean United Kingdom 7 123 114 93 92 75 9 364
Ryszard J. Chetkowski United States 13 427 3.5× 98 0.9× 120 1.3× 313 3.4× 96 1.3× 20 659
Benjamin Goldberg United States 11 131 1.1× 43 0.4× 56 0.6× 62 0.7× 47 0.6× 30 329
Carolina Gillio‐Meina Canada 15 177 1.4× 175 1.5× 172 1.8× 164 1.8× 222 3.0× 19 595
H. Pusch Austria 7 101 0.8× 60 0.5× 92 1.0× 52 0.6× 42 0.6× 30 253
Nandini A. Sheth India 9 147 1.2× 16 0.1× 41 0.4× 60 0.7× 64 0.9× 13 346
Gianni Russo Italy 15 132 1.1× 20 0.2× 193 2.1× 152 1.7× 340 4.5× 29 559
Ryou Misao Japan 14 199 1.6× 136 1.2× 187 2.0× 45 0.5× 111 1.5× 38 432
Gary M. Horowitz United States 12 240 2.0× 158 1.4× 15 0.2× 130 1.4× 65 0.9× 19 417
Denis Stygar Sweden 10 66 0.5× 160 1.4× 108 1.2× 176 1.9× 52 0.7× 10 481
U. Lundkvist Sweden 10 172 1.4× 86 0.8× 38 0.4× 69 0.8× 42 0.6× 13 470

Countries citing papers authored by Helen McLean

Since Specialization
Citations

This map shows the geographic impact of Helen McLean's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Helen McLean with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Helen McLean more than expected).

Fields of papers citing papers by Helen McLean

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Helen McLean. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Helen McLean. The network helps show where Helen McLean may publish in the future.

Co-authorship network of co-authors of Helen McLean

This figure shows the co-authorship network connecting the top 25 collaborators of Helen McLean. A scholar is included among the top collaborators of Helen McLean based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Helen McLean. Helen McLean is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Najafian, Nader, Anita Hill, Jörg Täubel, et al.. (2016). SP200A SUBCUTANEOUSLY ADMINISTERED INVESTIGATIONAL RNAI THERAPEUTIC (ALN-CC5) TARGETING COMPLEMENT C5 FOR TREATMENT OF PNH AND COMPLEMENT-MEDIATED DISEASES:INTERIM PHASE 1 STUDY RESULTS. Nephrology Dialysis Transplantation. 31(suppl_1). i153–i153. 1 indexed citations
4.
Carruthers, Alastair, Suzanne Bruce, Arlette De Coninck, et al.. (2014). Efficacy and Safety of OnabotulinumtoxinA for the Treatment of Crows Feet Lines. Dermatologic Surgery. 40(11). 1181–1190. 62 indexed citations
5.
Corker, Charles S., Helen McLean, William Hunter, et al.. (1980). Clinical trial with levo-norgestrel and testosterone oenanthate for male fertility control. European Journal of Endocrinology. 95(2). 251–257. 19 indexed citations
6.
Corker, Charles S., et al.. (1979). THE EFFECTS OF LOW DOSES OF CYPROTERONE ACETATE ON SOME FUNCTIONS OF THE REPRODUCTIVE SYSTEM IN NORMAL MEN. European Journal of Endocrinology. 91(3). 545–552. 24 indexed citations
7.
Corker, Charles S., et al.. (1978). SERUM-TESTOSTERONE DURING ORAL ADMINISTRATION OF TESTOSTERONE IN HYPOGONADAL MEN AND TRANSSEXUAL WOMEN. European Journal of Endocrinology. 87(3). 643–649. 4 indexed citations
8.
Sharpe, Richard M., William Wrixon, B. M. Hobson, et al.. (1977). Absence of hCG-Like Activity in the Blood of Women Fitted with Intra-Uterine Contraceptive Devices. The Journal of Clinical Endocrinology & Metabolism. 45(3). 496–499. 12 indexed citations
9.
McNatty, K. P., et al.. (1976). CONCENTRATION OF OESTROGENS AND ANDROGENS IN HUMAN OVARIAN VENOUS PLASMA AND FOLLICULAR FLUID THROUGHOUT THE MENSTRUAL CYCLE. Journal of Endocrinology. 71(1). 77–85. 207 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026